Intelligent Bio Solutions Inc. INBS

Full chart Compare
Set alert

Price alert · INBS

All alert types
1.77 USD +0.11 (+6.63%)

At closeNov 4, 2026, 7:21 AM EST

1.77 0.00 -0.03%

Pre-market · Nov 4, 7:21 AM ET

1.66 Day range 1.79
1.35 52-week range 24.90
YTD
-81.43%
1 year
-80.93%
Market cap
5.87M
Revenue (ttm)
3.11M
EPS (ttm)
-8.44
Shares out
4.39M
Forward P/E
3.83
YTD return
-81.43%
1-year return
-80.93%
Volume
28.88K
Avg volume
143.50K
Open
1.68
Previous close
1.66
Day's range
1.66 – 1.79
52-week range
1.35 – 24.90
Beta
4.72
Earnings date
Feb 14, 2025

YTD -6.12 (-77.57%)

51015Feb 3Apr 6Jun 4Aug 5Oct 51.77

Key statistics

Enterprise value
769.49K
PEG ratio
0.00
Price / sales
1.89
Price / book
0.56
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
64.20%
Free cash flow
-5.87M
Total cash
6.42M
Total debt
871.44K
Return on equity
-171.71%
Short % of float
8.73%
50-day average
1.53
200-day average
2.07

Next earnings

Feb 14, 2025

Expected Feb 14, 2025. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
INBS Revenue — quarterly 1.39M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
INBS Net income — quarterly -3.91M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
INBS EPS — quarterly -0.90
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026

Earnings

INBS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 14, 2025Dec 1, 20240.00———
Nov 7, 2024Sep 1, 20240.00-0.70——
Sep 19, 2024Jun 1, 20240.00———
May 8, 2024Mar 1, 20240.00———
May 8, 2024Mar 1, 20240.00-1.43——
Feb 9, 2024Dec 1, 2023-3.24———

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse. It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. The company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
ibs.inc

News

Your note

Sign in to keep a note on INBS — it syncs with the Stock Master app.

Insider holders

INBS insider holders
InsiderRelationLatest transactionDateShares held
SAKIRIS SPIRO KEVINChief Financial OfficerStock Award(Grant)Sep 24, 202453,759
SIMEONIDIS HARRYChief Executive OfficerStock Award(Grant)Sep 24, 202440,408
TOWERS CHRISTOPHERDirectorPurchaseOct 3, 20239,880

Institution ownership

INBS institution ownership
Holder% heldSharesValueReported
Alyeska Investment Group, L.p.4.70%206,199276.31KSep 29, 2024
CVI Holdings, LLC1.82%79,843106.99KJun 29, 2024
Geode Capital Management, LLC0.52%22,70630.43KSep 29, 2024
Vanguard Group Inc0.35%15,48520.75KSep 29, 2024
Adar1 Capital Management, LLC 0.12%5,3897.22KSep 29, 2024
UBS Group AG0.04%1,5512.08KSep 29, 2024

Fund ownership

INBS fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.40%17,64123.64KOct 30, 2024
Vanguard Extended Market Index Fund0.35%15,48520.75KSep 29, 2024
Fidelity Series Total Market Index Fund0.13%5,5997.50KOct 30, 2024
Fidelity Total Market Index Fund0.09%4,0975.49KOct 30, 2024